These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8578252)

  • 61. [Comments on the application of TNM classification of urinary bladder tumors in urological practice].
    Pazourek J
    Rozhl Chir; 1979 Dec; 58(12):815-8. PubMed ID: 542870
    [No Abstract]   [Full Text] [Related]  

  • 62. [Establishment of urological departments in Denmark].
    Aalkjoer V; Lund F
    Ugeskr Laeger; 1968 Apr; 130(17):741-2. PubMed ID: 5698370
    [No Abstract]   [Full Text] [Related]  

  • 63. The Planning of Urological Departments [Abridged].
    Chapman TL
    Proc R Soc Med; 1963 May; 56(5):431-2. PubMed ID: 19994258
    [No Abstract]   [Full Text] [Related]  

  • 64. The Planning of Urological Departments [Abridged].
    Shuttleworth KE
    Proc R Soc Med; 1963 May; 56(5):430-1. PubMed ID: 19994257
    [No Abstract]   [Full Text] [Related]  

  • 65. The Planning of Urological Departments [Abridged].
    Swinney J
    Proc R Soc Med; 1963 May; 56(5):428-30. PubMed ID: 19994256
    [No Abstract]   [Full Text] [Related]  

  • 66. The Planning of Urological Departments [Abridged].
    Lane V
    Proc R Soc Med; 1963 May; 56(5):427-8. PubMed ID: 19994255
    [No Abstract]   [Full Text] [Related]  

  • 67. OUT-PATIENT DEPARTMENTS.
    Br Med J; 1903 Jan; 1(2193):103. PubMed ID: 20760616
    [No Abstract]   [Full Text] [Related]  

  • 68. Changing Pattern of Bladder Cancer Cytology. (Haynal Imre University Experience).
    Kiss F; Salamon F; Rózsahegyi J
    Pathol Oncol Res; 1997; 3(1):47-50. PubMed ID: 11173625
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prolonging follow-up intervals for non-invasive bladder tumors: a randomized controlled trial.
    Olsen LH; Genster HG
    Scand J Urol Nephrol Suppl; 1995; 172():33-6. PubMed ID: 8578253
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Watchful waiting policy in recurrent Ta G1 bladder tumors.
    Gofrit ON; Pode D; Lazar A; Katz R; Shapiro A
    Eur Urol; 2006 Feb; 49(2):303-6; discussion 306-7. PubMed ID: 16413659
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of neurogenic bladder patients in The Netherlands: do urologists follow guidelines?
    Rikken B; Blok BF
    Neurourol Urodyn; 2008; 27(8):758-62. PubMed ID: 18508332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How do we follow patients with Ta grade 1-111 bladder tumors in Denmark?
    Nielsen KT; Lund L; Mommsen S; Olesen S
    Scand J Urol Nephrol Suppl; 1995; 172():27-31. PubMed ID: 8578252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.
    Oosterlinck W; Solsona E; Akaza H; Busch C; Goebell PJ; Malmström PU; Ozen H; Sved P
    Urology; 2005 Dec; 66(6 Suppl 1):75-89. PubMed ID: 16399417
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.